|
⚲
|
| Keyboard |
| Walbert Keli
✚
|
|
|---|---|
| CIK # | 0002051489 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002051489] | |
| 4 | [0002051489] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Walbert Keli | |
| Spruce Biosciences Inc | |
| Apellis Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2026-01-01 | Grant | 7,961 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Stock Option (Right to Buy) · derivative
|
2026-01-01 | Grant | 14,684 | $0.00 | |
|
Spruce Biosciences Inc SPRB
Stock Option (Right to Buy) · derivative
|
2025-12-11 | Grant | 3,400 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2025-01-08 | Grant | 9,090 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Stock Option (Right to Buy) · derivative
|
2025-01-08 | Grant | 15,388 | $33.00 | 507,804 |